BRPI0816887A2 - Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga - Google Patents

Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga

Info

Publication number: BRPI0816887A2
Authority: BR; Brazil
Prior art keywords: delivery system; drug delivery; treat; manufacture; prevent
Prior art date: 2007-09-21

Application number

Other languages

English (en)

Inventor

Wouter De Graaff

Raymond Zeeman

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-21

Filing date

2008-09-22

Publication date

2015-03-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40329142&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0816887(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-09-22 Application filed by Organon Nv filed Critical Organon Nv

2015-03-24 Publication of BRPI0816887A2 publication Critical patent/BRPI0816887A2/pt

2016-01-12 Publication of BRPI0816887A8 publication Critical patent/BRPI0816887A8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/142—Wirelike structures, e.g. loops, rings, spirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gynecology & Obstetrics (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Biotechnology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Dermatology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

BRPI0816887A 2007-09-21 2008-09-22 Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga BRPI0816887A8 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07018584		2007-09-21
PCT/EP2008/007975 WO2009036999A1 (en)	2007-09-21	2008-09-22	Drug delivery system

Publications (2)

Publication Number	Publication Date
BRPI0816887A2 true BRPI0816887A2 (pt)	2015-03-24
BRPI0816887A8 BRPI0816887A8 (pt)	2016-01-12

Family

ID=40329142

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816887A BRPI0816887A8 (pt)	2007-09-21	2008-09-22	Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga

Country Status (19)

Country	Link
US (2)	US8741329B2 (pt)
EP (1)	EP2200547A1 (pt)
JP (1)	JP5380452B2 (pt)
KR (2)	KR20100085054A (pt)
CN (1)	CN101827569B (pt)
AR (1)	AR066166A1 (pt)
AU (1)	AU2008300825B2 (pt)
BR (1)	BRPI0816887A8 (pt)
CA (1)	CA2699266C (pt)
CL (1)	CL2008002810A1 (pt)
CO (1)	CO6260045A2 (pt)
EC (1)	ECSP10010079A (pt)
MX (1)	MX2010003107A (pt)
MY (1)	MY163892A (pt)
NZ (1)	NZ583874A (pt)
RU (1)	RU2488369C2 (pt)
TW (1)	TW200930343A (pt)
WO (1)	WO2009036999A1 (pt)
ZA (1)	ZA201002014B (pt)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0222522D0 (en)	2002-09-27	2002-11-06	Controlled Therapeutics Sct	Water-swellable polymers
GB0417401D0 (en)	2004-08-05	2004-09-08	Controlled Therapeutics Sct	Stabilised prostaglandin composition
BRPI0617325B8 (pt)	2005-10-13	2021-06-22	Synthes Gmbh	luva biologicamente compatível
GB0613333D0 (en)	2006-07-05	2006-08-16	Controlled Therapeutics Sct	Hydrophilic polyurethane compositions
GB0613638D0 (en) *	2006-07-08	2006-08-16	Controlled Therapeutics Sct	Polyurethane elastomers
MX2009000053A (es) *	2006-07-12	2009-02-23	Controlled Therapeutics Sct	Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
GB0620685D0 (en) *	2006-10-18	2006-11-29	Controlled Therapeutics Sct	Bioresorbable polymers
CA2755828A1 (en)	2009-03-17	2010-09-23	Intervet International B.V.	Zoo-technical drug delivery device
US8568374B2 (en) *	2009-05-04	2013-10-29	Merck Sharp & Dohme B.V.	Intrauterine system
FI20095563A7 (fi) *	2009-05-20	2010-11-21	Bayer Schering Pharma Oy	Vaginaalinen antojärjestelmä
EP4108216A1 (en)	2009-06-03	2022-12-28	Forsight Vision5, Inc.	Anterior segment drug delivery
EP2547332B1 (en) *	2010-03-16	2018-08-29	Titan Pharmaceuticals, Inc.	Heterogeneous implantable devices for drug delivery
DE102010003494A1 (de) *	2010-03-31	2011-10-06	Bayer Schering Pharma Aktiengesellschaft	Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
AR081670A1 (es)	2010-06-29	2012-10-10	Leon Farma Sa Lab	Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US8580294B2 (en)	2010-10-19	2013-11-12	International Partnership For Microbicides	Platinum-catalyzed intravaginal rings
JP6068454B2 (ja) *	2011-06-06	2017-01-25	オーク・クレスト・インスティテュート・オブ・サイエンスＯａｋＣｒｅｓｔＩｎｓｔｉｔｕｔｅＯｆＳｃｉｅｎｃｅ	ウィッキング放出ウィンドウを利用した薬剤デリバリーデバイス
CN103917202B (zh)	2011-09-14	2016-06-29	弗赛特影像5股份有限公司	眼插入件装置和方法
EP3936133A1 (en)	2011-11-23	2022-01-12	TherapeuticsMD, Inc.	Natural combination hormone replacement formulations and therapies
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
TWI590843B (zh)	2011-12-28	2017-07-11	信迪思有限公司	膜及其製造方法
AR089765A1 (es) *	2012-01-23	2014-09-17	Bayer Oy	Un sistema para el suministro de un farmaco
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014066775A1 (en)	2012-10-26	2014-05-01	Forsight Vision5, Inc.	Ophthalmic system for sustained release of drug to eye
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20160144067A1 (en)	2013-06-21	2016-05-26	DePuy Synthes Products, Inc.	Films and methods of manufacture
US10137031B2 (en)	2013-11-14	2018-11-27	International Partnership For Microbicides, Inc.	Combination therapy intravaginal rings
US10596103B2 (en)	2013-12-11	2020-03-24	Merek Sharp & Dohme B.V.	Drug delivery system for delivery of anti-virals
US10413504B2 (en)	2013-12-11	2019-09-17	Merck Sharp & Dohme Corp.	Intravaginal ring drug delivery system
US10206932B2 (en)	2014-05-22	2019-02-19	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
WO2016168141A1 (en)	2015-04-13	2016-10-20	Forsight Vision5, Inc.	Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
CA3008941C (en) *	2015-12-21	2024-01-02	Bayer Oy	Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
CA3020153A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
US10406336B2 (en)	2016-08-03	2019-09-10	Neil S. Davey	Adjustable rate drug delivery implantable device
WO2018081138A1 (en) *	2016-10-24	2018-05-03	Yale University	Biodegradable contraceptive implants
WO2019222856A1 (en)	2018-05-24	2019-11-28	Nureva Inc.	Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
CA3087238A1 (en)	2018-05-24	2019-11-28	Celanese EVA Performance Polymers Corporation	Implantable device for sustained release of a macromolecular drug compound
BR112020023982A2 (pt)	2018-05-24	2021-02-23	Celanese Eva Performance Polymers Llc	dispositivo implantável para liberação prolongada de um composto de fármaco macromolecular
MX2021006426A (es) *	2018-12-11	2021-09-14	Lupin Inc	Sistema de suministro de farmaco para combinaciones de estrogeno de dosis ultra-baja y metodos y usos del mismo.
DE102019115343A1 (de) *	2019-06-06	2020-12-10	EVESTRA GmbH	Vaginalring für die hormonelle Kontrazeption
BR112023022439A2 (pt)	2021-04-26	2023-12-26	Celanese Eva Performance Polymers Llc	Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
EP4215180A1 (en) *	2022-01-21	2023-07-26	Sever Pharma Solutions	A drug delivery system
EP4215181A1 (en) *	2022-01-21	2023-07-26	Sever Pharma Solutions	An intravaginal ring
EP4487840A1 (en)	2023-07-07	2025-01-08	Sever Pharma Solutions	A three-layered intravaginal ring

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3545439A (en) *	1968-01-04	1970-12-08	Upjohn Co	Medicated devices and methods
US3854480A (en) *	1969-04-01	1974-12-17	Alza Corp	Drug-delivery system
US3995633A (en) *	1975-12-02	1976-12-07	The Procter & Gamble Company	Vaginal Medicament dispensing device
US3995634A (en) *	1975-12-02	1976-12-07	The Procter & Gamble Company	Vaginal cavity dispensing means and method
US4237885A (en) *	1978-10-23	1980-12-09	Alza Corporation	Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) *	1978-12-29	1981-10-06	The Population Council, Inc.	Intravaginal ring
DE3040978A1 (de)	1980-10-28	1982-05-27	Schering Ag, 1000 Berlin Und 4619 Bergkamen	Vaginalring
US4629449A (en) *	1982-07-29	1986-12-16	Alza Corporation	Vaginal dispenser for dispensing beneficial hormone
EP0180264A1 (en) *	1984-10-12	1986-05-07	Akzo N.V.	Release system for two or more active substances
ES2054784T3 (es)	1987-08-08	1994-08-16	Akzo Nv	Un metodo para la fabricacion de un implante.
AU3432689A (en)	1988-03-24	1989-10-16	Bukh Meditec A/S	Controlled release composition
DK606288D0 (da) *	1988-03-24	1988-10-31	Bukh Meditec	Praeparat
US5766632A (en) *	1993-10-01	1998-06-16	Legere Pharmaceuticals, Ltd.	Method of using lectins for contraception
JP3720386B2 (ja) *	1993-12-27	2005-11-24	住友製薬株式会社	薬物放出制御製剤
EP0836473B1 (en)	1995-07-04	2001-10-31	Akzo Nobel N.V.	Ring-shaped devices
US5972372A (en) *	1996-07-31	1999-10-26	The Population Council, Inc.	Intravaginal rings with insertable drug-containing core
FR2754179B1 (fr) *	1996-10-08	1998-12-24	Theramex	Nouvelle composition hormononale et son utilisation
TW358031B (en)	1997-04-11	1999-05-11	Akze Nobel N V	Drug delivery system for 2 or more active substances
CA2313196C (en)	1997-12-12	2006-07-11	Akzo Nobel Nv	A package for a vaginal ring
CA2315103A1 (en) *	1997-12-18	1999-06-24	Eli Lilly And Company	Crystalline teriparatide
TW586944B (en)	1998-05-29	2004-05-11	Sumitomo Pharma	Controlled release agent having a multi-layer structure
US6579533B1 (en) *	1999-11-30	2003-06-17	Bioasborbable Concepts, Ltd.	Bioabsorbable drug delivery system for local treatment and prevention of infections
US6476079B1 (en) *	1999-12-23	2002-11-05	Leiras Oy	Devices for the delivery of drugs having antiprogestinic properties
IL157771A0 (en) *	2001-03-27	2004-03-28	Galen Chemicals Ltd	Intravaginal drug delivery devices for the administration of an antimicrobial agent
EP1408876A4 (en) *	2001-06-22	2004-09-22	Durect Corp	ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
AU2002313517B2 (en)	2001-08-31	2007-09-06	Bayer Schering Pharma Oy	Drug delivery system
CN1596104A (zh) *	2001-09-28	2005-03-16	麦克内尔-Ppc股份有限公司	改进的释放剂型
US6992219B2 (en) *	2002-08-09	2006-01-31	Cephalon France	Modafinil polymorphic forms
TWI336627B (en) *	2003-05-23	2011-02-01	Organon Nv	Drug delivery system,and use and manufacturing method thereof
WO2005004837A1 (en)	2003-07-10	2005-01-20	Galen (Chemicals) Limited	Intravaginal drug delivery devices
JP2007530500A (ja) *	2004-03-24	2007-11-01	ナームローゼ・フエンノートチヤツプ・オルガノン	ポリエチレン酢酸ビニル共重合体に基づく薬物送達システム
TW200727920A (en)	2005-06-21	2007-08-01	Organon Nv	New regimens for oral monophasic contraceptives
PE20081895A1 (es) *	2007-03-26	2009-01-26	Theramex	Regimen anticonceptivo oral
KR101696301B1 (ko) *	2007-09-07	2017-01-13	마티 테라퓨틱스 인코포레이티드	치료 약제의 서방성 약물 코어

2008
- 2008-09-19 TW TW097136144A patent/TW200930343A/zh unknown
- 2008-09-19 AR ARP080104075A patent/AR066166A1/es unknown
- 2008-09-19 US US12/234,261 patent/US8741329B2/en active Active
- 2008-09-22 AU AU2008300825A patent/AU2008300825B2/en not_active Ceased
- 2008-09-22 CN CN2008801122070A patent/CN101827569B/zh not_active Expired - Fee Related
- 2008-09-22 MX MX2010003107A patent/MX2010003107A/es active IP Right Grant
- 2008-09-22 CA CA2699266A patent/CA2699266C/en not_active Expired - Fee Related
- 2008-09-22 KR KR1020107008582A patent/KR20100085054A/ko not_active Ceased
- 2008-09-22 NZ NZ583874A patent/NZ583874A/en not_active IP Right Cessation
- 2008-09-22 MY MYPI2010001185A patent/MY163892A/en unknown
- 2008-09-22 EP EP08802471A patent/EP2200547A1/en not_active Withdrawn
- 2008-09-22 RU RU2010115785/14A patent/RU2488369C2/ru not_active IP Right Cessation
- 2008-09-22 CL CL2008002810A patent/CL2008002810A1/es unknown
- 2008-09-22 BR BRPI0816887A patent/BRPI0816887A8/pt not_active IP Right Cessation
- 2008-09-22 KR KR20157008074A patent/KR20150046323A/ko not_active Ceased
- 2008-09-22 WO PCT/EP2008/007975 patent/WO2009036999A1/en not_active Ceased
- 2008-09-22 JP JP2010525267A patent/JP5380452B2/ja not_active Expired - Fee Related
2010
- 2010-03-19 CO CO10033049A patent/CO6260045A2/es not_active Application Discontinuation
- 2010-03-19 ZA ZA2010/02014A patent/ZA201002014B/en unknown
- 2010-03-31 EC EC2010010079A patent/ECSP10010079A/es unknown
2013
- 2013-10-31 US US14/068,233 patent/US20140056962A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2010115785A (ru)	2011-10-27
EP2200547A1 (en)	2010-06-30
ZA201002014B (en)	2010-11-24
US8741329B2 (en)	2014-06-03
AU2008300825A1 (en)	2009-03-26
KR20100085054A (ko)	2010-07-28
ECSP10010079A (es)	2010-04-30
US20090081278A1 (en)	2009-03-26
CN101827569A (zh)	2010-09-08
CA2699266A1 (en)	2009-03-26
MX2010003107A (es)	2010-04-21
WO2009036999A1 (en)	2009-03-26
BRPI0816887A8 (pt)	2016-01-12
AR066166A1 (es)	2009-07-29
US20140056962A1 (en)	2014-02-27
CA2699266C (en)	2016-08-30
MY163892A (en)	2017-11-15
JP5380452B2 (ja)	2014-01-08
JP2010539205A (ja)	2010-12-16
CL2008002810A1 (es)	2009-06-05
TW200930343A (en)	2009-07-16
NZ583874A (en)	2012-04-27
CO6260045A2 (es)	2011-03-22
CN101827569B (zh)	2013-10-16
KR20150046323A (ko)	2015-04-29
RU2488369C2 (ru)	2013-07-27
AU2008300825B2 (en)	2013-06-06

Publication	Publication Date	Title
BRPI0816887A2 (pt)	2015-03-24	Sistema de administração de droga, métodos de contracepção, para prover concomitantemente contracepção e tratar ou evitar uma doença sexualmente transmitida, e para fabricar o sistema de administração de droga em três-camadas, e, uso do sistema de administração de droga
BRPI0811262A2 (pt)	2014-11-04	Composto, composto ou sal do mesmo, composição farmacêutica, modulador de receptor de glicocorticóide, método para prevenção e/ou tratamento de bistúrbios metabólicos, doenças inflamatórias, doenças auto-imunes, doenças alérgicas, doenças do sistema nervoso central, doenças cardiovasculares, doenças relacionadas com homeostase ou glaucoma, e uso de pelo menos um composto ou um sal do mesmo
BRPI0818129A2 (pt)	2015-07-14	Sistema de transporte e administração de medicamento seguro
EP2313084A4 (en)	2014-03-05	INTRAUTERINE DISPOSAL SYSTEM FOR PREVENTION
EA200802208A1 (ru)	2009-04-28	Применение флибансерина для лечения расстройств полового влечения в постклимактерический период
BRPI0814759A2 (pt)	2015-03-03	Sistema de administração e notificação de medicamento específico de paciente
IL202614A0 (en)	2010-06-30	Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs
WO2009048594A3 (en)	2009-07-30	Multicomponent bioactive intravaginal ring
CL2007001132A1 (es)	2008-05-23	Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
LTPA2019508I1 (lt)	2019-05-10	Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
BRPI0806531A2 (pt)	2014-04-22	Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
DOP2007000102A (es)	2007-12-31	Arilimidazolonas y ariltriazolona sustituidas asi como su uso
BRPI0716196A2 (pt)	2013-11-12	Sistemas de distribuição de fármacos que compreendem soluções sólidas de fármacos fracamente básicos.
CR11493A (es)	2010-08-23	Sistema de administracion vaginal
BRPI0719060A2 (pt)	2014-02-04	Composto, prodroga, agente farmacêutico, métodos para inibir um receptor de angiotensina ii e/ou ativar um receptor ativado com proliferador de peroxisoma, e para prevenir ou tratar doenças ou condições, e, uso de um composto
WO2012083017A3 (en)	2012-08-23	Controlled release oral dosage forms of poorly soluble drugs and uses thereof
BRPI0818615A2 (pt)	2015-04-07	Sistema de aspiração para remoção de líquido descarregado pelo corpo humano, e sensor de líquido para o mesmo.
BRPI0906850A2 (pt)	2017-06-13	módulo terapêutico, sistema e dispositivo terapêutico para aliviar a dor e prover um efeito cicatrizante curativo, e, método para administrar alívio da dor com pelo menos um módulo terapêutico.
BRPI0815175A2 (pt)	2015-03-31	Dispositivo e procedimento para o diagnóstico ou para a preparação de diagnóstico e/ou para o monitoramento da terapia de doenças inflamatórias tal como artrite reumatóide
WO2007081949A3 (en)	2007-11-01	Small-volume oral transmucosal dosage forms
BRPI0816255A2 (pt)	2015-03-17	Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
BRPI1009860A2 (pt)	2016-03-08	composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
HRP20170250T1 (hr)	2017-04-07	Dvofazni pripravak lipidnih vezikula i postupak za liječenje cervikalne displazije intravaginalnom isporukom
ECSP088097A (es)	2008-02-20	Nuevos regímenes para dispositivos de administración controlada de fármacos para anticoncepción
BRPI0807285A2 (pt)	2014-05-06	"composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto"

Legal Events

Date	Code	Title	Description
2016-01-12	B25A	Requested transfer of rights approved	Owner name: MSD OSS B.V. (NL)
2018-03-20	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2018-07-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-11-06	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2480 DE 17-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.